Immunotherapy for head and neck cancer: where do we go from here?

被引：0
|
作者：
Ko, Eric C. [1 ]
Hanna, Glenn J. [2 ]
机构：
[1] Univ Massachusetts, UMass Mem Med Ctr, Chan Med Sch, Dept Radiat Oncol, 55 Lake Ave North, Worcester, MA 01655 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Ctr Head & Neck Oncol, 450 Brookline Ave, Boston, MA 02215 USA
来源：
IMMUNOTHERAPY | 2023年
关键词：
cancer immunology; checkpoint inhibitors; head and neck squamous cell cancer; immunotherapy; radiotherapy; SQUAMOUS-CELL CARCINOMA; OPEN-LABEL; PEMBROLIZUMAB; CETUXIMAB; RECURRENT; CHEMOTHERAPY; MULTICENTER; NIVOLUMAB; CARE;
D O I：
10.2217/imt-2023-0191
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Immunotherapy for head and neck cancer shows promising new directions - and challenges ahead. What can we learn from recent trials to improve patient selection and optimize combination therapy?
引用
收藏
页码：1497 / 1500
页数：4
相关论文
共 50 条
  • [31] Immunotherapy for squamous cell carcinoma of the head and neck - experience from Slovenia
    Plavc, Gaber
    Strojan, Primoz
    Azarija, Jelena
    Kuhar, Cvetka Grasic
    ONKOLOGIJA, 2021, 25 (01) : 6 - 11
  • [32] Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck Cancer
    Le, Xiuning
    Ferrarotto, Renata
    Wise-Draper, Trisha
    Gillison, Maura
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 899 - 906
  • [33] T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
    Zhao, Maryann
    Schoenfeld, Jonathan D.
    Egloff, Ann Marie
    Hanna, Glenn J.
    Haddad, Robert I.
    Adkins, Douglas R.
    Uppaluri, Ravindra
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025, 22 (02) : 83 - 94
  • [34] Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
    Runnels, Juliana
    Bloom, Julie R.
    Hsieh, Kristin
    Dickstein, Daniel R.
    Shi, Yuhao
    Jones, Brianna M.
    Lehrer, Eric J.
    Bakst, Richard L.
    BIOMEDICINES, 2023, 11 (08)
  • [35] The Top Five in Oncology: Where Do We Go From Here?
    Burstein, Harold J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (06): : 681 - 682
  • [36] Pain management in America: Where do we go from here?
    Gallagher, Rollin M.
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2019, 15 (06) : 400 - 403
  • [37] Homelessness and Emergency Medicine: Where Do We Go From Here?
    Doran, Kelly M.
    Raven, Maria C.
    ACADEMIC EMERGENCY MEDICINE, 2018, 25 (05) : 598 - 600
  • [38] Immunotherapy in head and neck cancer: evidence and perspectives
    Tosoni, Alicia
    Franceschi, Enrico
    Pasquini, Ernesto
    Lanese, Andrea
    Donini, Elisa
    Foschini, Maria Pia
    Dall'Olio, Danilo
    Brandes, Alba A.
    IMMUNOTHERAPY, 2017, 9 (16) : 1351 - 1358
  • [39] Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis
    Salvestrini, Viola
    Caini, Saverio
    Scricciolo, Melissa
    Saerens, Michael
    Bollen, Heleen
    Bonomo, Pierluigi
    Caparrotti, Francesca
    Lorini, Luigi
    Oliva, Marc
    Urbanowicz-Nijaki, Maria
    Szturz, Petr
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Hepatitis C Virus-Where are We Now and Where Do We Go From Here?
    Trooskin, Stacey
    Jhaveri, Ravi
    CLINICAL THERAPEUTICS, 2020, 42 (08) : 1425 - 1432
12345